Bank of Montreal
FUSN

Bank of Montreal’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bank of Montreal’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,927
Closed -$115K – 5412
2020
Q4 		$115K Buy
9,927
+4,462
+82% +$56K ﹤0.01% 3513
2020
Q3 		$64K Buy
+5,465
New +$74.7K ﹤0.01% 3318

Other funds holding FUSN

JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's FUSN Position: Q1 2021 in Review

Bank of Montreal sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2021, closing a stake of 9,927 shares — an estimated $115K sold.

Bank of Montreal first reported a position in FUSN in Q3 2020 and held it in 2 quarters. The position peaked at $115K in Q4 2020. 38 funds tracked by Wall St. Rank hold FUSN as of Q1 2021.

  • Bank of Montreal reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2021 after selling out during the quarter.
  • Bank of Montreal sold 9,927 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2021, an estimated $115K.
  • Bank of Montreal first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2020 and held it in 2 quarters.
  • Bank of Montreal's Fusion Pharmaceuticals Inc. Common Shares position peaked at $115K in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2021.

Based on Bank of Montreal's 13F filing for Q1 2021, filed 13 May 2021.